AI models need more data about biology, and OpenAI is paying to create it

OpenAI is funding the creation of new biological data to train AI models, following a proposal by clinical trial policy analyst Ruxandra Teslo to acquire detailed regulatory filings and manufacturing strategies from failed biotech companies via their bankruptcy proceedings. The effort addresses a shortage of biological data available for medical AI systems.

Last year, the clinical trial policy analyst Ruxandra Teslo posted an idea for super-charging medical AI systems: use data from failed biotech companies. By bidding at their bankruptcy proceedings, she proposed, it might be possible to obtain detailed regulatory filings, manufacturing strategies, an